Publications by authors named "Omneya Mohamed"
This study analyzed physical violence against physicians in Egypt from a medicolegal perspective. 88%, 42%, and 13.2% of participants were exposed to verbal, physical, and sexual violence.
View Article and Find Full Text PDFArticle Synopsis
- The study assesses the cost-effectiveness of upadacitinib as a first-line treatment for rheumatoid arthritis (RA) in Saudi Arabia, particularly for patients not responding well to previous treatments.
- An Excel model analyzed costs and health outcomes over a 10-year period, comparing current treatments with a new pathway involving upadacitinib followed by other treatments.
- Results showed that upadacitinib yielded more quality-adjusted life years (QALYs) at lower societal costs, indicating it could be a more effective option compared to existing therapies for both moderate and severe RA.
Objective: The current analysis assessed the economic and clinical burden of treatment-Resistant Depression (TRD) imposed on the Kingdom of Saudi Arabia (KSA), Kuwait and United Arab Emirates (UAE) from the societal perspective.
Methods: A Microsoft Excel based Markov model was developed to estimate the overall burden of disease imposed by TRD across KSA, Kuwait and UAE. Data for the models' adaptation were retrieved from literature and validated by country-specific key opinion leaders.
Background: Cladribine tablets are a newly launched short course oral treatment approved for high disease activity (HDA) relapsing multiple sclerosis (RMS). The current analysis assessed the cost-utility and budgetary impact of introducing cladribine tablets in HDA-RMS patients compared with other HDA-RMS therapies in Lebanon.
Methods: The global cost-utility and budget impact models were adapted from Lebanese National Social Security Fund (NSSF) perspective.
Objective: Cladribine tablets are the first short-course oral treatment approved for high disease activity relapsing-remitting multiple sclerosis (HDA-RRMS) across various countries. This analysis assessed the cost-effectiveness of introducing cladribine tablets as a treatment option for patients with high disease activity compared with other HDA-RRMS therapies in the Kingdom of Saudi Arabia (KSA).
Methods: The cost-effectiveness model was adapted from the KSA payer's perspective.
Background And Aims: The Middle East (ME) has a high prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), driven by obesity and type-2 diabetes mellitus (T2DM). Studies in Saudi Arabia (KSA) and United Arab Emirates (UAE) predict an escalating impact of NAFLD/NASH, particularly advanced fibrosis due to NASH (AF-NASH), increasing cases of cirrhosis, liver cancer and death. The scale of this burden in other ME countries is unknown with no reports of NAFLD/NASH healthcare resource utilization (HCRU) or costs.
View Article and Find Full Text PDFBackground: The SF-6D is a generic, six-dimensional health-related quality of life (HRQoL) measure derived from a selection of items from the SF-36.
Objectives: To translate, culturally adapt and validate the SF-6D for use in Arabic-speaking countries.
Methods: The International Quality of Life Assessment (IQOLA) methodology was followed.
Medicine price directly affects affordability and access to medicines particularly in countries where a major portion of pharmaceutical spending is through out-of-pocket payment, such as in the Asia Pacific region. We have undertaken a detailed appraisal of the pharmaceutical policy reforms to regulate drug prices in 3 developed (Australia, New Zealand, and South Korea) and 3 emerging (China, India, and Malaysia) economies of the Asia Pacific region. Despite continuous efforts by the authorities in adopting a wide range of reformatory pharmaceutical pricing policies to ensure affordability of medicines, these policies may not be optimal where drug prices were not lowered as expected (eg, in Korea).
View Article and Find Full Text PDFThe Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt.
Value Health Reg Issues
September 2016
Objectives: To describe the products with price changes and assess the impact of price changes on the products' price and affordability within the context of the Egyptian market.
Methods: A descriptive pre-post observational study was conducted. We selected March through June 2013 as the post-change observation period.